(Q35655927)

English

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children

scientific article published on January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children (English)

1 reference

Europe PubMed Central

9 August 2017

object named as

Michael D Decker

5

0 references

7

object named as

Ram Yogev

1 reference

Europe PubMed Central

9 August 2017

11

object named as

Sharon Nachman

1 reference

Europe PubMed Central

9 August 2017

Paige L Williams

3

object named as

Paige L Williams

1 reference

Europe PubMed Central

9 August 2017

author name string

George K Siberry

1

1 reference

Europe PubMed Central

9 August 2017

Meredith G Warshaw

2

1 reference

Europe PubMed Central

9 August 2017

Stephen A Spector

4

1 reference

Europe PubMed Central

9 August 2017

Patrick Jean-Philippe

6

1 reference

Europe PubMed Central

9 August 2017

Barbara E Heckman

8

1 reference

Europe PubMed Central

9 August 2017

Adam Manzella

9

1 reference

Europe PubMed Central

9 August 2017

Jhoanna Roa

10

1 reference

Europe PubMed Central

9 August 2017

Jorge Lujan-Zilbermann

12

1 reference

Europe PubMed Central

9 August 2017

IMPAACT P1065 Protocol Team

13

1 reference

Europe PubMed Central

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2012

1 reference

Europe PubMed Central

9 August 2017

Pediatric Infectious Disease Journal

1 reference

Europe PubMed Central

9 August 2017

31

1 reference

Europe PubMed Central

9 August 2017

1

1 reference

Europe PubMed Central

9 August 2017

47-52

1 reference

Europe PubMed Central

9 August 2017

Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Do children infected with HIV receiving HAART need to be revaccinated?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

27 July 2018

Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

25 September 2018

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

25 September 2018

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

25 September 2018

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

25 September 2018

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3252429

25 September 2018

Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21987006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21987006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/INF.0B013E318236C67B

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35655927&oldid=1970132382"